Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome
Abstract
Leishmaniasis is an emerging disease in HIV‐infected persons; visceral leishmaniasis is an AIDS‐defining opportunistic infection. The parasite that causes this infection is usually transmitted by the sandfly and occasionally by nonsterile needles among intravenous drug users. Diffuse cutaneous leishmaniasis (DCL) is a rare anergic variant of leishmanial infection with the characteristic presentation of numerous nonulcerating nodules with an abundant parasite load, lack of visceral involvement, negative reaction to the leishmanin skin test, and a chronic course with incomplete response to treatment and frequent relapses. We report a case of DCL that developed in the context of the immune reconstitution inflammatory syndrome (IRIS) in a man with AIDS following initiation of antiretroviral therapy. We also review DCL to emphasize the importance of recognizing and treating this evolving disease in the growing population of patients on immunorestorative therapy.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- CGRP sensory neurons promote tissue healing via neutrophils and macrophagesNature · 2024 · 2 shared tags
- Dimethyl Fumarate and Intestine: From Main Suspect to Potential Ally against Gut DisordersInternational Journal of Molecular Sciences · 2023 · 2 shared tags
- The Implications of Pruritogens in the Pathogenesis of Atopic DermatitisInternational Journal of Molecular Sciences · 2021 · 2 shared tags
- Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological MechanismsClinical Reviews in Allergy & Immunology · 2025 · 2 shared tags
- Dampness and moulds in workplace buildings: Associations with incidence and remission of sick building syndrome (SBS) and biomarkers of inflammation in a 10 year follow-up studyThe Science of The Total Environment · 2012 · 2 shared tags
- Prospective associations of leucocyte subtypes and obesity with the risk of developing cutaneous malignant melanoma in the UK Biobank cohortBMC Cancer · 2024 · 2 shared tags